A Phase 3 Randomized, Double Blind, Multi Center, Long Term Extension Study Investigating The Efficacy And Safety Of Pf 04965842, With Or Without Topical Medications, Administered To Subjects Aged 12 Years And Older With Moderate To Severe Atopic Dermatitis

Trial Profile

A Phase 3 Randomized, Double Blind, Multi Center, Long Term Extension Study Investigating The Efficacy And Safety Of Pf 04965842, With Or Without Topical Medications, Administered To Subjects Aged 12 Years And Older With Moderate To Severe Atopic Dermatitis

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Feb 2018

At a glance

  • Drugs PF 4965842 (Primary)
  • Indications Atopic dermatitis
  • Focus Adverse reactions; Registrational
  • Acronyms JADE EXTEND
  • Sponsors Pfizer
  • Most Recent Events

    • 08 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top